BioNexus Gene Lab Corp (BGLC)

CIK 1737523 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for BioNexus Gene Lab Corp.

Recent SEC filings

FiledFormAccession number
Aug 14, 202610-Q0001477932-26-005093
Aug 14, 202640001520138-26-000348
Aug 14, 202640001520138-26-000345
Aug 14, 202640001520138-26-000346
Aug 14, 2026SCHEDULE 13D0001520138-26-000354
Aug 14, 202640001520138-26-000349
Aug 14, 202640001520138-26-000347
Aug 7, 202630001520138-26-000322
Jul 31, 202630001520138-26-000294
Jul 31, 202630001520138-26-000300
Jul 31, 202630001520138-26-000301
Jul 31, 202630001520138-26-000293
Jul 31, 202630001520138-26-000295
Jul 28, 20268-K0001477932-26-004556
Jun 5, 20268-K0001477932-26-003658
May 15, 202610-Q0001477932-26-003242
Apr 14, 202610-K0001477932-26-002218
Mar 31, 2026NT 10-K0001477932-26-001877
Mar 17, 20268-K0001477932-26-001379
Feb 23, 20268-K0001477932-26-000964
Feb 3, 20268-K0001477932-26-000610
Dec 30, 20258-K0001477932-25-009240
Dec 23, 20258-K0001477932-25-009186
Dec 3, 2025DEF 14A0001477932-25-008757
Dec 2, 20258-K0001477932-25-008724